The Global Biosecurity Market is projected to grow significantly from US$ 17.45 billion in 2024 to US$ 40.93 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 8.9% over the forecast period from 2025 to 2034. The market plays a vital role in protecting human, animal, and environmental health from biological threats. These include infectious diseases, harmful pests, and deadly pathogens. Rising awareness and concern over global health emergencies and biological hazards are contributing to this strong market expansion.
Biosecurity measures are critical in various sectors, including agriculture, healthcare, food safety, and national defense. In agriculture, biosecurity practices focus on disease prevention among crops and livestock, helping avoid severe economic losses and ecological damage. In the healthcare sector, biosecurity helps control the spread of infectious diseases in clinical settings such as hospitals and laboratories. Meanwhile, the defense sector utilizes biosecurity systems to shield military personnel from potential biological warfare threats.
Key product segments in the biosecurity market include biocides and disinfectants, personal protective equipment (PPE), detection and monitoring tools, decontamination systems, and others. Among these, biocides and disinfectants held the leading market share in 2023, accounting for 32.4%. These products are essential in sterilizing environments, eliminating pathogens, and preventing disease transmission across both healthcare and agricultural settings.
By application, the market is segmented into agriculture, healthcare, food industry, defense and military, and other domains. Agriculture emerged as the leading application area, capturing 30.2% of the market share. This growth is primarily driven by the rising need to prevent livestock infections and crop contamination, especially in regions highly dependent on food production. Food security and supply chain stability remain top priorities globally, further strengthening this segment.
Government and regulatory agencies are key end users of biosecurity solutions. This segment accounted for 30.0% of total revenue share in 2023, highlighting their role in enforcement and implementation. Regulatory bodies are central in promoting health protocols, investing in preparedness, and responding to biological events. These agencies are also shaping standards that mandate the use of modern biosecurity technologies across public and private domains.
Technological advancements are supporting the growth of this market. Innovations such as biosensors, smart monitoring systems, and automated decontamination units are improving real-time detection and containment of threats. Additionally, global health agencies like the World Health Organization (WHO) are enforcing strict guidelines that influence purchasing decisions and compliance in critical sectors, further supporting market growth.
North America led the global biosecurity market in 2023 with a dominant 41.2% market share. This leadership is attributed to advanced healthcare infrastructure, strong regulatory frameworks, and proactive government investments. For instance, in March 2024, the U.S. Department of Agriculture (USDA) expanded biosecurity audits for poultry farms to combat the spread of highly pathogenic avian influenza (HPAI). Such initiatives reflect growing national efforts to enhance disease prevention and protect both public health and food supply chains.